 |
|
|
Rycarfa 100mg Tablets for dogs (pack of 100) |
|
Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post-operative pain.
|
|
Presentation
Each tablet contains:
Active substance: Carprofen 100 mg
Excipients: Ferric oxide red (E172) 3.04 mg; Ferric oxide black (E172) 1.90 mg
Round, dark brown, marbled tablets with visible darker spots, one-sided scored and bevel-edged. The tablets can be divided into equal halves.
Uses
Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease.
As a follow up to parenteral analgesia in the management of post-operative pain.
|
|
Dosage and administration
For oral administration.
An initial dose of 2 to 4 mg carprofen per kg body weight per day is recommended to be given as a single dose, or in two equally divided doses. Subject to clinical response, the dose may be reduced after 7 days to 2 mg carprofen/kg body weight/day given as a single dose.
Duration of treatment will be dependent upon the response seen, but the dog's condition should be re-appraised by the veterinary surgeon after 14 days therapy.
Advice on correct administration: To extend analgesic cover post-operatively, parenteral therapy with solution for injection may be followed with tablets at 4 mg/kg/day for up to 5 days.
|
|
Contraindications, warnings, etc
Contraindications: Do not use in cats.
Do not use in pregnant or lactating bitches.
Do not use in dogs less than 4 months of age.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia.
Adverse reactions: Typical undesirable effects associated with NSAIDs such as vomiting, soft faeces/diarrhoea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought.
As with other NSAIDs there is a risk of rare renal or idiosyncratic hepatic adverse events.
If you notice any serious effects or other effects not mentioned in this data sheet, please inform your veterinary surgeon.
Special warnings: For animal treatment only.
Keep out of the reach and sight of children.
Precautions for use in animals: Use in aged dogs may involve additional risk. If such use cannot be avoided, dogs may require careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated.
Precautions to be taken by the person administering the product to animals: In the event of accidental ingestion of the tablets, seek medical advice and show the doctor the package leaflet. Wash hands after handling the product.
Use during pregnancy and lactation: Studies in laboratory species (rat, rabbit) have shown evidence of foetotoxic effects of carprofen at doses close to the therapeutic dose. The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Do not use in pregnant or lactating bitches.
Interactions: Do not administer other NSAIDs and glucocorticoids concurrently or within 24 hours of administration of the product.
Carprofen is highly bound to plasma proteins and may compete with other highly bound drugs, which can lead to toxic effects.
Concurrent administration of potential nephrotoxic drugs should be avoided.
Overdose: Do not exceed the stated dose.
There is no specific antidote for carprofen overdose but general supportive therapy, as applied to clinical overdosage with NSAIDs, should be applied.
Pharmaceutical precautions
Do not store above 25°C.
Store in the original package in order to protect from light and moisture.
Return any halved tablet to the opened blister and use within 24 hours.
Do not use after the expiry date stated on the packaging after EXP.
Disposal: Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.
|
|
Legal category
POM-V
Packaging quantities
100 mg tablets are available in boxes of 20, 50, 100 and 500 tablets in blisters of 10 tablets. Not all pack sizes may be marketed.
Further information
To be supplied only on veterinary prescription.
Manufacturer: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
Marketing authorisation holder (if different from distributor)
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Marketing authorisation number
Vm 01656/4013.
Significant Changes
GTIN (Global Trade Item No)
Rycarfa 100 mg Tablets for Dogs
03838989585051
|
|
|
